Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Biopharmaceutics and Pharmacokinetics: Overview

Biopharmaceutics and Pharmacokinetics: Overview

Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Pharmaceutical Equivalents

Pharmaceutical Equivalents

As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Categorizing health beliefs among cancer survivors using latent profile analysis to identify targets for promoting medication adherence and quality of life.

Scientific reports·2026

Same author

Improving Outcomes for Black Adults with Diabetes: The Power of Peer Support in the Multidisciplinary Care Team.

Journal of multidisciplinary healthcare·2026

Same author

Methodological Reflections from Engaging Five Culturally and Linguistically Unique U.S. Muslim Populations.

Healthcare (Basel, Switzerland)·2026

Same author

Culturally adapting diabetes self-management education: a community engaged co-design approach.

Translational behavioral medicine·2026

Same author

Investigating the Added Value of a Culturally Tailored Peer Support Intervention for Black Adults with Diabetes: A Randomized Mixed Methods Pilot Trial.

Diabetes, metabolic syndrome and obesity : targets and therapy·2025

Same author

The Effect of the <i>Dobbs v. Jackson Women's Health Organization</i> Ruling on Obstetric Care Use in the Medicaid Insured Population.

Journal of health care for the poor and underserved·2025

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Exploring consumer understanding and preferences for pharmacy quality information.

Olayinka O Shiyanbola¹, Jane R Mort²

¹Division of Social and Administrative Sciences, University of Wisconsin-Madison . Madison, WI ( United States ). oshiyanbola@pharmacy.wisc.edu.

Pharmacy Practice

|January 13, 2015

Summary

Consumers with chronic illnesses are interested in pharmacy quality measures but often misunderstand them. They prefer overall pharmacy ratings, condition-specific data, and star ratings for clarity.

Keywords:

Community Pharmacy Services Consumer Satisfaction Health Care Pharmacies Quality Assurance United States

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products

Published on: August 22, 2017

Related Experiment Videos

Last Updated: Apr 18, 2026

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products

Published on: August 22, 2017

Area of Science:

Health Services Research
Consumer Health Informatics
Pharmacy Practice

Background:

Understanding consumer perspectives on pharmacy quality is crucial for improving healthcare.
Existing pharmacy quality measures are not always clear to the public.

Purpose of the Study:

To assess consumer comprehension of pharmacy quality measures.
To identify consumer preferences for pharmacy quality information presentation.

Main Methods:

Combined semi-structured focus groups and surveys with adults managing chronic illnesses.
Analyzed understanding of Pharmacy Quality Alliance measures and preferences for rating systems and data formats.

Main Results:

Participants were largely unfamiliar with quality measures, with varying understanding levels.
Preferred overall pharmacy ratings, condition-specific data, city-level comparisons, and star ratings over other formats.

Conclusions:

Consumers are interested in pharmacy quality information, but current measures require clearer communication.
Findings can inform the design of user-friendly pharmacy quality reporting systems.